Filing Details
- Accession Number:
- 0001079973-23-000013
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-01-04 18:03:10
- Reporting Period:
- 2022-12-14
- Accepted Time:
- 2023-01-04 18:03:10
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1128189 | Protokinetix Inc. | PKTX | Pharmaceutical Preparations (2834) | 943355026 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1516077 | Edward Clarence Smith | 1409 Peachtree Road Daytona Beach FL 32114 | President & Ceo | Yes | Yes | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2022-12-14 | 94,089 | $0.02 | 13,329,249 | No | 4 | P | Indirect | see footnote |
Common Stock | Acquisiton | 2022-12-15 | 78,400 | $0.03 | 13,407,649 | No | 4 | P | Indirect | see footnote |
Common Stock | Acquisiton | 2022-12-16 | 65,000 | $0.03 | 13,472,649 | No | 4 | P | Indirect | see footnote |
Common Stock | Acquisiton | 2022-12-21 | 100,000 | $0.03 | 13,572,649 | No | 4 | P | Indirect | see footnote |
Common Stock | Acquisiton | 2022-12-30 | 1,850,000 | $0.02 | 41,964,443 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Indirect | see footnote |
No | 4 | P | Indirect | see footnote |
No | 4 | P | Indirect | see footnote |
No | 4 | P | Indirect | see footnote |
No | 4 | P | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Warrant | Disposition | 2022-12-18 | 216,666 | $0.00 | 0 | $0.12 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2022-12-18 | No | 4 | J | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 1,850,000 | Indirect | see footnote |
Reported Derivative Holdings
Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option | $0.03 | 2028-12-06 | 27,600,000 | 27,600,000 | Direct | |
Common Stock | Stock Option | $0.03 | 2028-12-06 | 4,750,000 | 4,750,000 | Direct | |
Common Stock | Warrant | $0.05 | 2022-03-30 | 2024-03-15 | 600,000 | 600,000 | Direct |
Common Stock | Warrant | $0.05 | 2022-03-18 | 2024-03-15 | 1,000,000 | 1,000,000 | Direct |
Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
---|---|---|---|
2028-12-06 | 27,600,000 | 27,600,000 | Direct |
2028-12-06 | 4,750,000 | 4,750,000 | Direct |
2024-03-15 | 600,000 | 600,000 | Direct |
2024-03-15 | 1,000,000 | 1,000,000 | Direct |
Footnotes
- Shares purchased on the open market.
- Shares held by the Clarence E. Smith Trusts.
- This transaction was executed in multiple trades at prices ranging from $0.0270 to $0.0328. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $0.0290 to $0.0313. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- Shares purchased in private placement of the Company.
- Shares held by Mr. Smith's retirement account.
- Options granted pursuant to Amended 2017 Stock Option and Stock Bonus Plan on December 7, 2022. Fully vested.
- Expiration of warrants for no value received.